drugset / Trial / NCT01658813

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

NCT01658813

Phase 2 Completed 18 enrolled Western Regional Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the combination of a 5-Fluorouracil (5-FU) and interferon, which is able to stimulate the immune system to kill cancer cells, will help to increase tumor shrinkage in previously-treated metastatic gastrointestinal, kidney, or lung Cancer.

Timeline

Start
2012-07
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule
Subject interferon alfa-2b Protein / enzyme biologic